|Natural history of human immunodefiency virus type 1 infection in children: a five-year prospective study in Rwanda|
R Spira, P Lepage, P Msellati, P Van de Perre, V Leroy, A Simonon, ...
Pediatrics 104 (5), e56-e56, 1999
|Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease|
M Lemaitre, J Kirchgesner, A Rudnichi, F Carrat, M Zureik, F Carbonnel, ...
Jama 318 (17), 1679-1686, 2017
|Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases|
J Kirchgesner, M Lemaitre, F Carrat, M Zureik, F Carbonnel, R Dray-Spira
Gastroenterology 155 (2), 337-346. e10, 2018
|Mobility and the spread of human immunodeficiency virus into rural areas of West Africa|
E Lagarde, M Schim Van Der Loeff, C Enel, B Holmgren, R Dray-Spira, ...
International journal of epidemiology 32 (5), 744-752, 2003
|Correlates of late HIV diagnosis: implications for testing policy|
C Delpierre, R Dray-Spira, L Cuzin, B Marchou, P Massip, T Lang, F Lert, ...
International journal of STD & AIDS 18 (5), 312-317, 2007
|Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial|
CC Iwuji, J Orne-Gliemann, J Larmarange, E Balestre, R Thiebaut, ...
The lancet HIV 5 (3), e116-e125, 2018
|Predictors identified for losses to follow-up among HIV-seropositive patients|
E Lanoy, M Mary-Krause, P Tattevin, R Dray-Spira, C Duvivier, P Fischer, ...
Journal of clinical epidemiology 59 (8), 829-835. e1, 2006
|Impact of diabetes on work cessation: data from the GAZEL cohort study|
E Herquelot, A Guéguen, S Bonenfant, R Dray-Spira
Diabetes care 34 (6), 1344-1349, 2011
|Social health inequalities during the course of chronic HIV disease in the era of highly active antiretroviral therapy|
R Dray-Spira, F Lert
Aids 17 (3), 283-290, 2003
|Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000|
F Dabis, V Leroy, K Castetbon, R Spira, ML Newell, R Salamon
Aids 14 (8), 1017-1026, 2000
|Prevalence of cutaneous disorders in a population of HIV-infected patients: southwestern France, 1996|
R Spira, M Mignard, MS Doutre, P Morlat, F Dabis
Archives of dermatology 134 (10), 1208-1212, 1998
|Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial|
A Badje, R Moh, D Gabillard, C Guéhi, M Kabran, JB Ntakpé, J Le Carrou, ...
The Lancet Global Health 5 (11), e1080-e1089, 2017
|Socio-economic conditions, health status and employment among persons living with HIV/AIDS in France in 2001|
R Dray-Spira, F Lert, C Marimoutou, AD Bouhnik, Y Obadia
AIDS care 15 (6), 739-748, 2003
|Employment loss following HIV infection in the era of highly active antiretroviral therapies|
R Dray-Spira, A Persoz, F Boufassa, A Gueguen, F Lert, T Allegre, ...
The European Journal of Public Health 16 (1), 89-95, 2006
International Encyclopedia of Ethics, 1-9, 2013
|Disease severity, self-reported experience of workplace discrimination and employment loss during the course of chronic HIV disease: differences according to gender and education|
R Dray-Spira, A Gueguen, F Lert
Occupational and environmental medicine 65 (2), 112-119, 2008
|Factors correlated with disclosure of HIV infection in the French Antilles and French Guiana: results from the ANRS-EN13-VESPA-DFA Study|
K Bouillon, F Lert, R Sitta, A Schmaus, B Spire, R Dray-Spira
AIDS (London, England) 21, S89, 2007
|Heterogeneous response to HAART across a diverse population of people living with HIV: results from the ANRS-EN12-VESPA Study|
R Dray-Spira, B Spire, I Heard, F Lert, VESPA Study Group
Aids 21, S5-S12, 2007
|Educational disparities in mortality among adults with diabetes in the US|
R Dray-Spira, TL Gary-Webb, FL Brancati
Diabetes care 33 (6), 1200-1205, 2010
|Living and working with HIV in France in 2003: results from the ANRS-EN12-VESPA Study|
R Dray-Spira, F Lert, VESPA Study Group
Aids 21, S29-S36, 2007